Focuses on the development of a method to immunize against self tumor necrosis factor-&alpha (TNF). Successful use of therapeutic monoclonal antibodies against the pro-inflammatory cytokine TNF-α Stimulation of a booster-dependent T-cell dependent anti-TNF-α response.